ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SKF ProShares UltraShort Financials New

31.7096
0.00 (0.00%)
Pre Market
Last Updated: 12:52:49
Delayed by 15 minutes
Name Symbol Market Type
ProShares UltraShort Financials New AMEX:SKF AMEX Exchange Traded Fund
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 31.7096 0 12:52:49

2nd UPDATE:PPF Pulls EGM Petition,Mum On Sanofi's Zentiva Bid

09/02/2009 4:05pm

Dow Jones News


ProShares UltraShort Fin... (AMEX:SKF)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more ProShares UltraShort Fin... Charts.

The second-largest shareholder in Czech generic drug maker Zentiva NV (BAAZEN.PR) Monday called off its petition for an extraordinary general meeting, removing at least one hurdle in Sanofi-Aventis SA's (2057.FR) EUR1.8 billion takeover offer for Zentiva.

Czech financial company PPF Group NV with Generali PPF Holding BV, the Eastern European joint venture of PPF Group and Italian insurer Assicurazioni Generali SpA (G.MI), together hold a 24.3% stake in Zentiva and earlier bid CZK950 per share for Zentiva, which was turned down by Zentiva's management.

Units of PPF and Generali PPF Holding withdrew a petition to the district court in Amsterdam to convene an EGM, saying that Monday Zentiva answered questions about commitments made by Zentiva regarding the Sanofi offer, PPF's spokesman Alexej Bechtin said in a statement.

Dow Jones Newswires asked PPF if withdrawing the petition for an EGM means PPF will support the Sanofi bid and sell its stake.

"No, it does not - we do not comment on our further steps regarding the Sanofi bid. This is just a reflection of today's EGM where our previous questions were satisfactorily answered," Bechtin said.

Earlier Monday Zentiva's board reiterated their support for Sanofi's CZK1150 per share takeover offer at an EGM.

The offer from Sanofi, the largest shareholder in Zentiva with a 24.9% stake, is open until Feb. 20.

At 1511 GMT, Zentiva shares were up 1.3% at CZK1142, amid a higher overall market.

The European Commission cleared the French pharmaceutical giant's move Feb. 4, provided Sanofi-Aventis sell 15 drugs in central and eastern Europe.

Company Web site: www.zentiva.cz

-By Sean Carney, Dow Jones Newswires; +420 222 191 375; sean.carney@dowjones.com

 
 

1 Year ProShares UltraShort Fin... Chart

1 Year ProShares UltraShort Fin... Chart

1 Month ProShares UltraShort Fin... Chart

1 Month ProShares UltraShort Fin... Chart